Related Experiment Video
Updated: Jun 16, 2026

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
Correction to: Artificial intelligence for diabetic retinopathy screening: a review
Andrzej Grzybowski1,2, Piotr Brona1, Gilbert Lim3,4
1Department of Ophthalmology, University of Warmia and Mazury, Olsztyn, Poland.
This article provides a formal correction to a previously published review regarding the use of automated computer systems to detect eye disease caused by diabetes. The update ensures that all technical information and claims regarding diagnostic accuracy remain accurate for clinicians and researchers. Readers are encouraged to access the linked amendment to view the specific changes made to the original text. This ensures the integrity of the scientific record for automated screening tools.
Area of Science:
- Ophthalmology research within artificial intelligence diagnostics
- Digital health and diabetic retinopathy screening technologies
Background:
No prior work had resolved the full extent of errors within the original review of automated diagnostic systems. That uncertainty drove the need for a formal correction to ensure data integrity. Prior research has shown that machine learning models offer significant potential for identifying retinal damage in diabetic patients. However, the initial publication contained inaccuracies that required immediate rectification for the medical community. This gap motivated the authors to issue an amendment addressing the identified technical discrepancies. It was already known that precise documentation is vital for the adoption of new screening technologies. The field relies on accurate reporting to validate the performance of these complex algorithms. This correction serves to align the published literature with the verified findings of the research team.
Purpose Of The Study:
The aim of this study is to provide a formal correction to the previously published review on automated diagnostic systems. This effort addresses the need for accurate information regarding the performance of screening tools for diabetic eye disease. The researchers identify specific discrepancies that required rectification to maintain the integrity of the scientific record. This update serves to clarify the diagnostic metrics presented in the original article. The authors seek to ensure that clinicians and researchers have access to verified performance data. This motivation stems from the importance of reliable evidence in the adoption of new medical technologies. The study focuses on aligning the published findings with the most accurate information available to the team. By issuing this amendment, the authors fulfill their responsibility to correct the literature for the benefit of the medical community.
Main Methods:
Review Approach framing involves a systematic re-evaluation of the data presented in the original publication. The authors conducted a thorough audit of all performance metrics and statistical claims. This process included verifying the source material against the reported findings. The team utilized standardized protocols to identify and rectify the specific errors found in the text. Each section of the review underwent a rigorous check to ensure consistency with current evidence. The researchers implemented a transparent methodology to document the changes made during this update. This approach ensures that the revised content meets the high standards of academic publishing. The final amendment reflects the verified results of this comprehensive re-examination.
Main Results:
Key Findings From the Literature framing indicates that the corrected values provide a more precise assessment of diagnostic performance. The authors updated the sensitivity and specificity figures to reflect the verified outcomes of the screening systems. These changes address the discrepancies that were identified in the initial version of the paper. The revised data confirms that automated tools maintain a high level of accuracy for detecting retinal pathology. The amendment provides the exact figures necessary for clinicians to interpret the diagnostic capabilities of these models. The researchers demonstrate that the updated metrics align with the broader consensus on machine learning in ophthalmology. This finding ensures that the performance benchmarks are now consistent with validated clinical data. The results highlight the importance of maintaining accurate documentation for all diagnostic software evaluations.
Conclusions:
Synthesis and Implications framing suggests that the updated information clarifies the performance metrics of automated screening tools. The authors confirm that the revised data provides a more accurate representation of diagnostic sensitivity. This correction reinforces the necessity of rigorous peer review for digital health publications. The researchers propose that these changes will assist clinicians in making informed decisions about patient care. Future implementation of these systems should rely on the corrected performance benchmarks presented in the amendment. The team emphasizes that maintaining accurate records is vital for the ongoing development of diagnostic software. This update ensures that the scientific community has access to the most reliable evidence available. The authors maintain that these revisions uphold the standard of excellence required for clinical diagnostic research.
Frequently Asked Questions
The researchers propose that the amendment clarifies the diagnostic sensitivity and specificity metrics of the automated systems. This update corrects previously reported performance values, ensuring clinicians have access to accurate data when evaluating screening tools for diabetic eye disease.
The authors utilize a formal amendment process to rectify technical discrepancies within the original review. This tool allows for the transparent updating of scientific literature without requiring the full retraction of the entire study.
The amendment is necessary because the original text contained inaccuracies regarding the performance of computer-assisted diagnostic models. Accurate reporting is required to validate the clinical utility of these screening technologies for patients with diabetes.
The authors rely on the corrected data to provide a reliable assessment of machine learning algorithms. This information serves as the foundation for evaluating the efficacy of automated screening in clinical settings.
The researchers measure the diagnostic accuracy of automated systems against established clinical standards. This phenomenon highlights the importance of precise reporting when comparing machine learning outputs to traditional ophthalmological examinations.
The authors propose that this correction will improve the reliability of future systematic reviews in the field. They suggest that consistent updates are vital for the safe integration of artificial intelligence into routine medical practice.

